[...] the federal government, responding to congressional inquiries, says Medicaid for years has been paying too much for EpiPens because the emergency shot is classified incorrectly as a generic medicine. The federal government says EpiPen is a branded drug, which means the drug’s maker, Mylan, should have been paying a far higher rebate under the...